LEVOSIMENDAN IN PREOPERATION THERAPY FOR CARDIOSURGERY IN PATIENTS WITH CHRONIC HEART FAILURE
Aim. To evaluate the efficacy of action of the calcium sensitizer levosimendan (LS) in patients with various grade of heart failure (HF) severity before cardiosurgery.Material and methods. LS was applied as a part of HF treatment while preparing patients for surgery in 2-4 days. Performed dose was 0...
Saved in:
| Main Authors: | M. A. Babaev, A. A. Eremenko, O. V. Dymova, P. V. Polyakova, S. V. Fedulova, Yu. V. Frolova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2017-03-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1598 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction
by: K. V. Kopeva, et al.
Published: (2023-04-01) -
Comparative Assessment of the Preventive Use of Intra-Aortic Baloon Counterpulsation and Levosimendan in Patients with Coronary Heart Disease and Low Left Ventricular Ejection Fraction
by: V. A. Boboshko, et al.
Published: (2012-02-01) -
HEART TRANSPLANTATION FROM DONORS WITH LEFT VENTRICULAR EJECTION FRACTION <40%
by: V. N. Poptsov, et al.
Published: (2018-06-01) -
Gamma-glutamyl transpeptidase is a promising biological marker of heart failure
by: A. M. Alieva, et al.
Published: (2022-07-01) -
Coronary flow reserve in patients with heart failure with preserved ejection fraction
by: A. V. Mochula, et al.
Published: (2022-03-01)